BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 35347488)

  • 1. Comparative efficacy of amitriptyline, duloxetine and pregabalin for treating fibromyalgia in adults: an overview with network meta-analysis.
    Alberti FF; Becker MW; Blatt CR; Ziegelmann PK; da Silva Dal Pizzol T; Pilger D
    Clin Rheumatol; 2022 Jul; 41(7):1965-1978. PubMed ID: 35347488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of Amitriptyline and US Food and Drug Administration-Approved Treatments for Fibromyalgia: A Systematic Review and Network Meta-analysis.
    Farag HM; Yunusa I; Goswami H; Sultan I; Doucette JA; Eguale T
    JAMA Netw Open; 2022 May; 5(5):e2212939. PubMed ID: 35587348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Meta-analysis of duloxetine vs. pregabalin and gabapentin in the treatment of diabetic peripheral neuropathic pain.
    Quilici S; Chancellor J; Löthgren M; Simon D; Said G; Le TK; Garcia-Cebrian A; Monz B
    BMC Neurol; 2009 Feb; 9():6. PubMed ID: 19208243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative efficacy and tolerability of duloxetine, pregabalin, and milnacipran for the treatment of fibromyalgia: a Bayesian network meta-analysis of randomized controlled trials.
    Lee YH; Song GG
    Rheumatol Int; 2016 May; 36(5):663-72. PubMed ID: 27000046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiepileptic drugs for chronic non-cancer pain in children and adolescents.
    Cooper TE; Wiffen PJ; Heathcote LC; Clinch J; Howard R; Krane E; Lord SM; Sethna N; Schechter N; Wood C
    Cochrane Database Syst Rev; 2017 Aug; 8(8):CD012536. PubMed ID: 28779491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination pharmacotherapy for the treatment of fibromyalgia in adults.
    Thorpe J; Shum B; Moore RA; Wiffen PJ; Gilron I
    Cochrane Database Syst Rev; 2018 Feb; 2(2):CD010585. PubMed ID: 29457627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative efficacy and acceptability of amitriptyline, duloxetine and milnacipran in fibromyalgia syndrome: a systematic review with meta-analysis.
    Häuser W; Petzke F; Üçeyler N; Sommer C
    Rheumatology (Oxford); 2011 Mar; 50(3):532-43. PubMed ID: 21078630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative efficacy and harms of duloxetine, milnacipran, and pregabalin in fibromyalgia syndrome.
    Häuser W; Petzke F; Sommer C
    J Pain; 2010 Jun; 11(6):505-21. PubMed ID: 20418173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serotonin and noradrenaline reuptake inhibitors (SNRIs) for fibromyalgia.
    Welsch P; Üçeyler N; Klose P; Walitt B; Häuser W
    Cochrane Database Syst Rev; 2018 Feb; 2(2):CD010292. PubMed ID: 29489029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparing the efficacy and safety of duloxetine and amitriptyline in the treatment of fibromyalgia: overview of systematic reviews.
    de Farias ÁD; Eberle L; Amador TA; da Silva Dal Pizzol T
    Adv Rheumatol; 2020 Jul; 60(1):35. PubMed ID: 32641165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Duloxetine for pain in fibromyalgia in adults: a systematic review and a meta-analysis.
    Lian YN; Wang Y; Zhang Y; Yang CX
    Int J Neurosci; 2020 Jan; 130(1):71-82. PubMed ID: 31487217
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmacological management of fibromyalgia: a Bayesian network meta-analysis.
    Migliorini F; Maffulli N; Eschweiler J; Knobe M; Tingart M; Colarossi G
    Expert Rev Clin Pharmacol; 2022 Feb; 15(2):205-214. PubMed ID: 35184627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost effectiveness of pregabalin in the treatment of fibromyalgia from a UK perspective.
    Choy E; Richards S; Bowrin K; Watson P; Lloyd A; Sadosky A; Zlateva G
    Curr Med Res Opin; 2010 Apr; 26(4):965-75. PubMed ID: 20178405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparing duloxetine and pregabalin for treatment of pain and depression in women with fibromyalgia: an open-label randomized clinical trial.
    Bidari A; Moazen-Zadeh E; Ghavidel-Parsa B; Rahmani S; Hosseini S; Hassankhani A
    Daru; 2019 Jun; 27(1):149-158. PubMed ID: 30877484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Duloxetine for fibromyalgia syndrome: a systematic review and meta-analysis.
    Migliorini F; Maffulli N; Eschweiler J; Baroncini A; Bell A; Colarossi G
    J Orthop Surg Res; 2023 Jul; 18(1):504. PubMed ID: 37461044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patterns of health care utilization related to initiation of amitriptyline, duloxetine, gabapentin, or pregabalin in fibromyalgia.
    Kim SC; Landon JE; Lee YC
    Arthritis Res Ther; 2015 Jan; 17(1):18. PubMed ID: 25627453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of different antidepressants and anticonvulsants in central poststroke pain: A network meta-analysis and systematic review.
    Chen KY; Li RY
    PLoS One; 2022; 17(10):e0276012. PubMed ID: 36227855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination of pregabalin with duloxetine for fibromyalgia: a randomized controlled trial.
    Gilron I; Chaparro LE; Tu D; Holden RR; Milev R; Towheed T; DuMerton-Shore D; Walker S
    Pain; 2016 Jul; 157(7):1532-40. PubMed ID: 26982602
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.